A comprehensive approach for integration of toxicity and cancer risk assessments

Regulatory Toxicology and Pharmacology

Volumn 29, Issue 1, 1999, Pages 23-36

  Butterworth, Byron E ^a   Bogdanffy, Matthew S ^b  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHLOROFORM; DNA; VINYL ACETATE;

ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; DOSE RESPONSE; DRUG CARCINOGENICITY; DRUG SAFETY; GENOTOXICITY; HUMAN; MAXIMUM ALLOWABLE CONCENTRATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RISK ASSESSMENT; TOXICITY TESTING;

EID: 0033016320     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1273     Document Type: Article

References (86)

1. Ahmadizadeh M., Echt R., Kuo C., Hook J. B. Sex and strain differences in mouse kidney: Bowman's capsule morphology and susceptibility to chloroform. Toxicol. Lett. 20:1984;161-172.
2. Ames B. N., Gold L. S. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science. 249:1990;970-971.
3. Andelman J. B. Human exposures to volatile halogenated organic chemicals in indoor and outdoor air. Environ. Health Perspect. 62:1985;313-318.
4. Ashby J., Tennant R. W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257:1991;229-306.
5. Bogdanffy M. S., Dreef-van der Meulen H. C., Beems R. B., Feron V. J., Rickard R. W., Cascieri T. C., Tyler T. R., Vinegar M. B. Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse. Fundam. Appl. Toxicol. 23:1994;215-229.
6. Bogdanffy M. S., Gladnick N. L., Kegelman T., Frame S. R. Four-week inhalation cell proliferation study of the effects of vinyl acetate on rat nasal epithelium. Inhal. Toxicol. 9:1997a;331-350.
7. Bogdanffy M. S., Jarabek A. M. Understanding mechanisms of inhaled toxicants: Implications for replacing default factors with chemical-specific data. Toxicol. Lett. 82/83:1995;919-932.
8. Bogdanffy M. S., Matison B. H., Kuykendall J. R., Harman A. E. Critical factors in assessing risk from exposure to nasal carcinogens. Mutat. Res. 380:1997b;125-141.
9. Bogdanffy M. S., Randall H. W., Morgan K. T. Histochemical localization of aldehyde dehydrogenase in the respiratory tract off the Fischer-344 rat. Toxicol. Appl. Pharmacol. 82:1986;560-567.
10. 1. Toxicol. Appl. Pharmacol. 88:1987;183-194.
11. Bogdanffy M. S., Taylor M. L. Kinetics of carboxylesterase-mediated hydrolysis of the nasal carcinogen vinyl acetate. Drug Metab. Dispos. 21:1993;1107-1111.
12. Butterworth B. E., Popp J. A., Conolly R. B., Goldsworthy T. L. Chemically-induced cell proliferation in carcinogenesis. Mechanisms of Carcinogenesis in Risk Identification. 1992;. p. 279-305.
13. Butterworth B. E., Conolly R. B., Morgan K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 93:1995;129-146.
14. Butterworth, B. E. Templin, M. V. Larson, J. L. Wolf, D. C. Goldsworthy, T. L. 1997, The use of induced cell proliferation data in selecting doses for carcinogenicity studies, Principles for the Selection of Doses in Chronic Rodent Bioassays, 93, 109, ILSI Press, Washington, DC.
15. 1. Environ. Mol. Mutagen. 31:1998;248-256.
16. Casanova-Schmitz M., David R. M., Heck H. díA. Oxidation of formaldehyde and acetaldehyde in rat nasal mucosal homogenates. Biochem. Pharmacol. 33:1984;1137-1142.
17. Cattley R. C., Marsman D. M., Popp J. A. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator Wy-14,643 in rat liver. Carcinogenesis. 12:1991;469-473.
18. Clayson D. B. Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays? Mutat. Res. 221:1989;53-67.
19. Clemens T. L., Hill R. N., Bullock L. P., Johnson W. D., Sultatos L. G., Vesell E. S. Chloroform toxicity in the mouse: Role of genetic factors and steroids. Toxicol. Appl. Pharmacol. 48:1979;117-130.
20. Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science. 249:1990;1007-1011.
21. Columbano A., Rajalakshmi S., Sarma D. S. R. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res. 41:1981;2079-2083.
22. Conolly R. B., Butterworth B. E. Biologically based dose response model for hepatic toxicity: A mechanistically based replacement for traditional estimates of noncancer risk. Toxicol. Lett. 82/83:1995;901-906.
23. Craddock V. M. Cell proliferation and experimental liver cancer. Cameron H. M., Linsell C. A., Warwick G. P. Liver Cell Cancer. 1976;153-201 Elsevier/North-Holland Biomedical Press, Amsterdam.
24. Craun G. F. Safety of Water Disinfection: Balancing Chemical and Microbial Risks. 1993;ILSI Press, Washington.
25. Crump K. S., Clewell H. J., Andersen M. E. Cancer and non-cancer risk assessment should be harmonized. BELLE Newslett. 5:1996;2-4.
26. Dellarco V. L. A mutagenicity assessment of acetaldehyde. Mutat. Res. 195:1988;1-20.
27. 2uD. Cancer Res. 51:1991;3512-3521.
28. Drinkwater N. R. Genetic control of hepatocarcinogenesis in C3H mice. Drug Metabol. Rev. 26:1994;201-208.
29. Flamm G. W., Lehman-McKeeman L. D. The human relevance of the renal tumor-inducing potential ofD. Regul. Toxicol. Pharmacol. 13:1991;70-86.
30. Fry R. J. M., Storer J. B. External radiation carcinogenesis. Adv. Radiat. Biol. 13:1987;31-90.
31. Gaylor D. W., Zheng Q. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents. Risk Anal. 16:1996;221-225.
32. Grasso P., Hardy J. Strain differences in natural incidence and response to carcinogens. Butler W. H., Newberne P. M. Mouse Hepatic Neoplasia. 1975;111-131 Elsevier, New York.
33. He S.-M., Lambert B. Induction and persistence of SCE-inducing damage in human lymphocytes exposed to vinyl acetate and acetaldehyde in vitro. Mutat. Res. 158:1985;201-208.
34. He S.-M., Lambert B. Acetaldehyde-induced mutation at the hprt locus in human lymphocytes in vitro. Envrion. Mol. Mutagen. 16:1990;57-63.
35. Heck H. d'A. Bladder stones and bladder cancer: A review of the toxicology of terephthalic acid. Butterworth B. E., Slaga T. J. Nongenotoxic Mechanisms in Carcinogenesis. 1987;233-243 CSH Press, Cold Spring Harbor.
36. Hill R. N., Clemens T. L., Lui D. K., Vesell E. S. Genetic control of chloroform toxicity in mice. Science. 190:1975;159-161.
37. Huff J., Haseman J., Rall D. Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu. Rev. Pharmacol. Toxicol. 31:1991;621-652.
38. Interagency Regulatory Liaison Group Working Group on Risk Assessment. Scientific bases for identification of potential carcinogens and estimation of risks. J. Natl. Cancer Instit. 63:1979;241-268.
39. International Life Sciences Institute (ILSI), 1997, An Evaluation of EPA's Proposed Guidelines for Carcinogen Risk Assessment Using Chloroform and Dichloroacetate As Case Studies: Report of an Expert Panel, 1126.
40. International Programme on Chemical Safety (IPCS), 1994, Environmental Health Criteria 163: Chloroform, World Health Organization, Geneva, Switzerland.
41. Jo W. K., Weisel C. P., Lioy P. J. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal. 10:1990;575-580.
42. 1. Fundam. Appl. Toxicol. 5:1985;760-769.
43. Kuykendall J. R., Bogdanffy M. S. Reaction kinetics of DNA-histone crosslining by vinyl acetate and acetaldehyde. Carcinogenesis. 13:1992;2095-2100.
44. Kuykendall J. R., Taylor M. L., Bogdanffy M. S. Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated. Toxicol. Appl. Pharmacol. 123:1993;283-292.
45. Lam C.-W., Casanova M., Heck H. díA. Decreased extractability of DNA from proteins in the rat nasal mucosa after acetaldehyde exposure. Fundam. Appl. Toxicol. 6:1986;541-550.
46. Lambert B., Chen Y., He S.-M., Sten M. in vitro. Mutat. Res. 146:1985;301-303.
47. 1. Environ. Mol. Mutagen. 23:1994a;132-136.
48. 1. Fundam. Appl. Toxicol. 22:1994b;90-102.
49. 1. Fundam. Appl. Toxicol. 23:1994c;537-543.
50. Larson J. L., Wolf D. C., Butterworth B. E. Induced regenerative cell proliferation in livers and kidneys of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology. 95:1995;73-86.
51. 1. Fundam. Appl. Toxicol. 30:1996;118-137.
52. Lee G-H., Drinkwater N. R. Hepatocarcinogenesis in BXH recombinant inbred strains of mice: Analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol. Carcinog. 14:1995;190-197.
53. Lehman A. J., Fitzhugh O. G. 100-Fold margin of safety: Association of food and drug officials. U.S.Q. Bull. 118:1954;33-35.
54. 1. Toxicol. Appl. Pharmacol. 148:1998;137-147.
55. 1. Drug Chem. Toxicol. 8:1985;1-42.
56. Monticello T. M., Swenberg J. A., Gross E. A., Leininger J. R., Kimbell J. S., Seilkop S., Starr T. B., Gibson J. E., Morgan K. T. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res. 56:1996;1012-1022.
57. Morgan K. T. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment. Toxicol. Pathol. 25:1997;291-307.
58. Morita T. Low pH leads to sister-chromatid exchanges and chromosomal aberrations, and its clastogenicity is S-dependent. Mutat. Res. 334:1995;301-308.
59. National Cancer Institute (NCI), 1976, Report on Carcinogenesis Bioassay of Chloroform, PB-264 018, National Technical Information Service, Springfield, VA.
60. Science and Judgment in Risk Assessment. 1994;National Academy Press, Washington.
61. Norppa H., Tursi F., Pfaffli P., Maki-Paakkanenn J., Jarventaus H. Chromosome damage induced by vinyl acetate throughin vitro. Cancer Res. 45:1985;4816-4821.
62. Pegram R. A., Andersen M. E., Warren S. H., Ross T. M., Claxton L. D. GlutathioneSSalmonella typhimurium: Toxicol. Appl. Pharmacol. 144:1997;183-188.
63. 1. Fundam. Appl. Toxicol. 23:1994;87-92.
64. Pereira M. A., Lin L. C., Lippitt J. M., Herren S. L. Trihalomethanes as initiators and promoters of carcinogenesis. Environ. Health Perspect. 46:1982;151-156.
65. Pitot H. C. Fundamentals of Oncology. 1986;Dekker, New York.
66. Reitz R. H., Mendrala A. L., Corley R. A., Quast J. F., Gargas M. L., Andersen M. E., Statts D. A., Conolly R. B. Estimating the risk of liver cancer associated with human exposures to chloroform. Toxicol. Appl. Pharmacol. 105:1990;443-459.
67. Reininghaus W., Koestner A., Klimisch H. K. Chronic toxicity and oncogenicity bioassay of inhaled methyl acrylate and n-butyl acrylate in Sprague-Dawley rats. Food Chem. Toxicol. 29:1991;329-339.
68. Richardson F. C., Boucheron J. A., Dyroff M., Popp J. A., Swenberg J. A. Biochemical and morphological studies of heterogeneous lobe responses in hepatocarcinogenesis. Carcinogenesis. 7:1986;247-251.
69. Schulte-Hermann R., Schuppler J., Timmermann-Trosiener I., Ohde G., Bursch W., Berger H. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver. Environ. Health Perspect. 50:1983;185-194.
70. Sipi P., Jarvantaus H., Norppa H. Sister-chromatid exchanges induced by vinyl esters and respective carboxylic acids in cultured human lymphocytes. Mutat. Res. 279:1992;75-82.
71. Swenberg J. A., Maronpot R. R. Chemically induced cell proliferation as a criterion in selecting doses for long-term bioassays. Butterworth B. E., Slaga T. J., Farland W., McClain M. Chemically Induced Cell Proliferation: Implications for Risk Assessment. 1991;245-251 Wiley-Liss, New York.
72. Templin M. V., Larson J. L., Butterworth B. E., Jamison K. C., Wong B. A., Wolf D. C. A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam. Appl. Toxicol. 32:1996a;109-125.
73. Templin M. V., Jamison K. C., Wolf D. C., Morgan K. T., Butterworth B. E. Comparison of chloroform-induced toxicity in the kidneys, liver, and nasal passages of male Osborne-Mendel and F-344 rats. Cancer Lett. 104:1996b;71-78.
74. 1. Cancer Lett. 108:1996c;225-231.
75. 1. Carcinogenesis. 19:1998;187-193.
76. Tennant R. W., Margolin B. H., Shelby M. D., Zeiger E., Hasman J. K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
77. U.S. Environmental Protection Agency (U.S. EPA), 1985, Health Assessment Document for Chloroform, EPA/600/8-84/004F, U.S. Environmental Protection Agency, Washington, DC.
78. Fed. Reg. 51:1986;33992-34003.
79. Fed. Reg. 59:1994;38668-38829.
80. Fed. Reg. 61:1996;17960-18011.
81. U.S. Environmental Protection Agency (U.S. EPA), 1998a, IRIS: Integrated Risk Information System. Database on chloroform, http://www.epa.gov/iris/ , 11, 1998.
82. Fed. Reg. 63:1998b;15674-15692.
83. Walker V. E., Fennell T. R., Boucheron J. A., Fedtke N., Ciroussel F., Swenberg J. A. Macromolecular adducts of ethylene oxide: A literature review and a time-course study on the formation of 7-(2-hydroxyethyl)guanine following exposures of rats by inhalation. Mutat. Res. 233:1990;151-164.
84. Weisburger J. H., Williams G. M. Carcinogen testing: Current problems and new approaches. Science. 214:1981;401-407.
85. 1. Proceedings of the Fifty-Third Annual Meeting of the Japanese Cancer Association. 1994.
86. [See also, Matsushima, T, 1994, An Inhalation Carcinogenesis Study of Chloroform: Initial Report. Japan Bioassay Laboratory, Japan Industrial Safety and Health Association.